跳轉至內容
Merck
全部照片(1)

重要文件

SHCLNV

Sigma-Aldrich

MISSION® shRNA

Lentiviral Particles

登入查看組織和合約定價


About This Item

分類程式碼代碼:
41106609

品質等級

技術

capture ELISA: 106 VP/mL using p24

運輸包裝

dry ice

儲存溫度

−70°C

尋找類似的產品? 前往 產品比較指南

一般說明

我们全面的shRNA产品系列包括超过150,000个预克隆的shRNA构建体,靶向超过15,000个人类基因和15,000个小鼠基因。该文库可用于:基因家族集合:与特定功能类(如激酶和离子通道)相关的基因集合;基因靶标集合,针对靶标基因的shRNA克隆集合;以及单个shRNA克隆。我们的shRNA和慢病毒制造平台利用专门实验室,配备最先进的机器人技术、液体处理和实验室信息管理系统(LIMS),为您的RNAi研究需求提供卓越的质量和服务。
慢病毒颗粒广泛用于转导各种细胞系。MISSION®慢病毒颗粒含有水疱性口炎病毒(VSV-G)假型,可转导细胞范围更大。 此外,该慢病毒颗粒可将shRNA稳定整合到分裂和非分裂细胞的基因组中。 MISSION生物技术团队稳定产出高质量慢病毒,让我们的客户可以直接开展RNAi实验,不用再将宝贵的时间浪费在繁琐的慢病毒制备上。 我们最高的滴度是106 VP/mL。 不同于腺病毒转染需要高度过量病毒,慢病毒转染更为高效,MOI值(感染复数)低至1。

應用

MISSION® shRNA已用于:
  • 转染和转导
  • 构建表达shRNA的稳定细胞系
  • 建立α-辅肌动蛋白-4(ACTN4)敲低细胞系
  • 转导RAW 264.7细胞

其他說明

想要查看实验方案和应用数据,请访问 sigma.com/shrna

法律資訊

使用本产品需遵守一个或多个 许可协议。
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany

儲存類別代碼

12 - Non Combustible Liquids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


從最近期的版本中選擇一個:

分析證明 (COA)

Lot/Batch Number

抱歉,我們目前沒有在線上提供本產品的COA

如果您需要協助,請聯絡 客戶支援

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Sejal Desai et al.
Biochimica et biophysica acta, 1865(1), 196-208 (2017-10-23)
Acquired radioresistance accompanied with increased metastatic potential is a major hurdle in effective radiotherapy of breast cancers. However, the nature of their inter-dependence and the underlying mechanism remains largely intangible. By employing radioresistant (RR) cell lines, we herein demonstrate that
Xia Liu et al.
Oncology letters, 16(5), 5868-5874 (2018-10-20)
Ovarian cancer (OC) has the highest fatality rates of all gynecological malignancies worldwide. The epithelial-to-mesenchymal transition (EMT) serves an essential role in the progression of OC. An improved understanding of the molecular mechanism underlying EMT in OC may increase the
Barbara D Boyan et al.
Scientific reports, 8(1), 8588-8588 (2018-06-07)
Successful osseointegration of an endosseous implant involves migration and differentiation of mesenchymal stem cells (MSCs) on the implant surface. Micro-structured, hydrophilic titanium surfaces direct MSCs to undergo osteoblastic differentiation in vitro, in the absence of media additives commonly used in
Vera Mugoni et al.
Cell research, 29(6), 446-459 (2019-04-27)
Although targeted therapies have proven effective and even curative in human leukaemia, resistance often ensues. IDH enzymes are mutated in ~20% of human AML, with targeted therapies under clinical evaluation. We here characterize leukaemia evolution from mutant IDH2 (mIDH2)-dependence to
Inhibitors of endoplasmic reticulum alpha-glucosidases potently suppress hepatitis C virus virion assembly and release
Qu X, et al.
Antimicrobial agents and chemotherapy, 55(3), 1036-1044 (2011)

文章

MISSION® Lentiviral shRNA

Our lentiviral vector systems are developed with enhanced safety features. Numerous precautions are in place in the design of our lentiviruses to prevent replication. Good handling practices are a must.

Successful targeting relies on optimizing key sensitive steps in the process, including lentiviral transduction. Below are some helpful handling and titration tips from our R&D lentiviral experts.

條款

You are not alone designing successful CRISPR, RNAi, and ORF experiments. Sigma-Aldrich was the first company to commercially offer lentivirus versions of targeted genome modification technologies and has the expertise and commitment to support new generations of scientists.

FACS (Fluorescence-Activated Cell Sorting) provides a method for sorting a mixed population of cells into two or more groups, one cell at a time, based on the specific light scattering and fluorescence of each cell. This method provides fast, objective, and quantitative recording of fluorescent signals from individual cells.

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務